Revelation Biosciences Warrant
REVBW
11 hedge funds and large institutions have $6.76K invested in Revelation Biosciences Warrant in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.
15% less funds holding
Funds holding: 13 → 11 (-2)
53.6% less ownership
Funds ownership: 75.62% → 22.02% (-54%)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
64% less capital invested
Capital invested by funds: $18.6K → $6.76K (-$11.8K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$381 |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$103 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
-$2.07K |
| 2 |
PVI
Pine Valley Investments
Marlton,
New Jersey
|
-$501 |
| 3 |
Walleye Trading
New York
|
-$135 |
| 4 |
TSS
Two Sigma Securities
New York
|
-$64 |
| 5 |
CS
Clear Street
New York
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
LA
1
Linden Advisors
New York
| $2.51K | – | – | – |
|
|
YCM
2
Yakira Capital Management
Westport,
Connecticut
| $1.73K | – | – | – |
|
|
PVI
3
Pine Valley Investments
Marlton,
New Jersey
| $695 | -$501 | -42,858 | -30% |
|
|
4
Walleye Trading
New York
| $654 | -$135 | -11,555 | -11% |
|
|
WAM
5
Wolverine Asset Management
Chicago,
Illinois
| $383 | +$381 | +32,550 | +147% |
|
6
Jane Street
New York
| $350 | – | – | – |
|
|
7
Citadel Advisors
Miami,
Florida
| $268 | +$103 | +8,835 | +30% |
|
|
TSS
8
Two Sigma Securities
New York
| $72 | -$64 | -5,460 | -35% |
|
|
9
Walleye Capital
New York
| $71 | -$2.07K | -176,927 | -95% |
|
10
UBS Group
Zurich,
Switzerland
| $18 | -$2 | -156 | -6% |
|
|
PIS
11
POM Investment Strategies
Raleigh,
North Carolina
| $7 | – | – | – |
|
|
CAC
12
Cowen and Company
New York
| – | -$1.5K | -99,900 | Closed |
|
|
CS
13
Clear Street
New York
| – | -$2 | -100 | Closed |
|
REVBW Hedge Fund Activity: Q4 2024 in Review
11 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q4 2024, worth a combined $6.76K — down 64% from $18.6K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of REVBW and 0 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 2 added.
The largest buyer was Wolverine Asset Management, adding an estimated $381. The largest seller was Walleye Capital, cutting an estimated $2.07K.
- 11 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q4 2024, down from 13 in Q3 2024.
- Funds reported $6.76K of Revelation Biosciences Warrant stock for Q4 2024, down 64% quarter-over-quarter.
- 0 funds opened new Revelation Biosciences Warrant positions in Q4 2024 and 2 closed out, a net change of -2 holders.
- The largest Revelation Biosciences Warrant buyer in Q4 2024 was Wolverine Asset Management, an estimated $381 added.
- The largest Revelation Biosciences Warrant seller in Q4 2024 was Walleye Capital, an estimated $2.07K sold.
Based on aggregated 13F filings for Q4 2024.